OMED Health
- Company typePrivate
- Founded2022
- HeadquartersCambridge, United Kingdom
- Headcount51–100
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What OMED Health does
OMED Health is a UK-based healthcare diagnostics company founded in 2022 and headquartered at Cambridge Science Park. The company operates as a consumer-facing division of Owlstone Medical, the breath analysis group whose mission is to save 100,000 lives and $1.5B in healthcare costs through Breath Biopsy technology. OMED Health specialises in at-home breath-based diagnostic testing for SIBO (Small Intestinal Bacterial Overgrowth) and IMO (Intestinal Methanogen Overgrowth), targeting patients with chronic digestive symptoms who have often been misdiagnosed with IBS.
The company's core product is the OMED Health Breath Analyzer, a portable, reusable, Class I In Vitro Diagnostic (IVD) medical device that uses metal oxide sensors to measure hydrogen and methane gas concentrations in breath in parts per million (ppm), paired with a smartphone app (iOS/Android) that guides the test, logs symptoms and lifestyle data, and delivers doctor-reviewed results. Published performance data shows mean absolute error of ~3.8 ppm (hydrogen) and ~2.3 ppm (methane), comparable to hospital-grade breath testing. The company has expanded the platform with the OMED Inside Insights in-clinic VOC test (covering gut, liver, and lung health), botanical SIBO/IMO antimicrobial supplements, post-treatment Gut Support, and the Gut Reset+ subscription plan, supported by a GMC-registered doctor consultation pathway and a UK partner pharmacy for prescription delivery.
OMED Health generates revenue through a hybrid model combining one-off hardware sales of the Breath Analyzer, recurring substrate and consumable sales, prescription consultation fees, supplement sales, and subscription health plans. Go-to-market is multi-channel: a clinician-guided sales motion through an affiliate network of dietitians, nutritionists, GI specialists, and functional medicine practitioners who order tests via a dedicated Practitioner Portal, complemented by direct-to-consumer sales, the Welbeck Health Partners enterprise channel, and the Functional Gut Clinic co-development relationship. Commercial operations are currently limited to Great Britain, with the app footprint already present in the US and broader Europe.
OMED Health firmographics
Firmographics- Name
- OMED Health
- Legal name
- OMED Health
- Website
- https://omedhealth.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
OMED Health industry classification
Industry- Product category
- Medical Diagnostics
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry) (HLAHACAD)
- akta.pro secondary industry
- Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate) (HLAHAGAI)
Keywords
Where OMED Health is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
OMED Health business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain, Infrastructure
Revenue model
- Breath Analyzer Device Sales: Sale of the OMED Health Breath Analyzer hardware device to patients and healthcare professionals. The device is a reusable, portable handheld breath analyzer that measures hydrogen and methane for SIBO/IMO testing.
- SIBO/IMO Testing Kits and Substrates: Recurring revenue from test substrates (glucose or lactulose) delivered to patients' homes for breath testing. Clinicians order tests through the Practitioner Portal for direct delivery to patients.
- Prescription Consultations and Medications: Doctor-led prescription consultations for patients who have tested positive for SIBO. OMED doctors review results and prescribe targeted antibiotic treatment, dispensed and delivered via trusted partner UK pharmacy. Additional cost beyond standard testing.
- Gut Health Supplements: Sale of clinically supported herbal antimicrobial supplements for SIBO and IMO treatment, including SIBO Antimicrobials (oregano, berberine, ginger, garlic extracts) and IMO Antimicrobials. Includes gut support products for post-treatment recovery.
- Health Plans (Gut Reset+): Personalised doctor-led health plans combining breath tests and treatments in comprehensive packages for complete gut recovery programs.
Go-to-market motion3 records
Distribution channels5 records
Marketing channels7 records
OMED Health product offering
Product offeringCore offering
OMED Health develops and sells the Breath Analyzer, a portable Class I IVD medical device that uses metal oxide sensors to measure hydrogen and methane gas concentrations in breath for at-home diagnosis of SIBO and IMO, paired with a smartphone app for guided testing. It also offers SIBO/IMO testing services reviewed by OMED doctors, antimicrobial and gut support supplements, prescription consultations, the Gut Reset+ personalised health plan, and the OMED Inside Insights in-clinic breath test, all supported by a Practitioner Portal for healthcare professionals.
Product overview
OMED Health is a patient-centric digital health platform built around its core OMED Health Breath Analyzer device and companion smartphone app. The platform offers at-home hydrogen and methane breath testing for SIBO (Small Intestinal Bacterial Overgrowth) and IMO (Intestinal Methanogen Overgrowth) diagnosis, reviewed by OMED Health doctors. Adjacent products include botanical antimicrobial supplements (SIBO Antimicrobials, IMO Antimicrobials) and post-treatment Gut Support for microbiome rebalancing. Prescription escalation is available via Prescription Consultation with UK pharmacy delivery. The Gut Reset+ Plan bundles testing and treatments into a personalised doctor-led programme. Advanced in-clinic microbiome analysis is offered through OMED Inside Insights. Healthcare professionals access the ecosystem via the Practitioner Portal and affiliate network.
Differentiator
Problem solved
Functional benefit
Brands
- OMED Health Inside Insights: Advanced in-clinic breath test to help understand how lifestyle and environment may influence gut, liver and lung health through analysis of breath chemicals.
- OMED Health Breath Analyzer
- OMED Health App
- Practitioner Portal
- Gut Reset+
Products and services
- OMED Health Breath Analyzer Portable, handheld, reusable Class I IVD medical device using metal oxide sensors to measure hydrogen and methane gas concentrations in breath in parts per million (ppm) in real time, paired with the OMED Health App to enable at-home SIBO and IMO breath testing for patients and clinicians in Great Britain.
- OMED Health App Smartphone application (iOS and Android) that pairs with the OMED Health Breath Analyzer to guide users through testing, log symptoms, food and drink intake, and lifestyle data, display real-time hydrogen and methane results, and deliver OMED Health doctor diagnoses and treatment recommendations.
- OMED Inside Insights Advanced in-clinic breath test that analyses volatile organic compounds (VOCs) in breath to provide insights into gut health (SCFAs, BCFAs, organic sulfur compounds), liver health (limonene), and pollution exposure (indoor chemicals, smoke markers, cooking emissions), delivered through specialist clinics.
- SIBO/IMO Test At-home hydrogen and methane breath test using the OMED Breath Analyzer with a glucose or lactulose substrate; results are reviewed by OMED Health doctors who issue a SIBO (hydrogen-dominant) or IMO (methane-dominant) diagnosis, with reports accessible via the Practitioner Portal as PDFs.
- SIBO Antimicrobials Clinically supported botanical antimicrobial supplement formulated with oregano, garlic, turmeric, ginger, thyme, a digestive enzyme blend, and black pepper extracts, designed as part of a clinician-guided treatment plan for hydrogen-dominant SIBO.
- IMO Antimicrobials Precision antimicrobial supplement formulated for methanogen overgrowth (IMO/methane-dominant SIBO), containing peppermint, clove, and activated charcoal to support motility and clear archaeal overgrowth.
- Gut Support Post-treatment supplement containing L-glutamine, aloe vera, and probiotics to support gut lining repair, mucosal recovery, and long-term microbiome balance following SIBO or IMO antimicrobial treatment.
- Prescription Consultation GMC-registered doctor-led consultation for patients who test positive for SIBO and need prescription antibiotic treatment, including review of test results, personalised treatment plan, electronic prescription, and medication dispensed and delivered via a UK-registered partner pharmacy.
- Gut Reset+ Plan Personalised doctor-led subscription health plan that bundles breath testing and antimicrobial treatments, including ongoing clinician guidance, repeat testing, and tailored treatment protocols for comprehensive gut recovery.
- Practitioner Portal Web-based dashboard for healthcare professionals in the affiliate network to order SIBO/IMO test kits for patients, track order shipping in real time, access instant test reports (downloadable as PDFs), and manage the full SIBO testing clinical workflow.
Companies that use OMED Health
Customer profileNamed customers8 records
Segments3 records
Ideal customer profiles2 records
OMED Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
OMED Health partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and major.
- Welbeck Health PartnerscoreWelbeck Health Partners has adopted OMED Health's home-based SIBO testing pathway across its network of specialist outpatient healthcare centres in the UK. This partnership enables Welbeck to offer next-generation SIBO diagnostics to their patients through the OMED platform.
- Functional Gut CliniccorePartnership with the Functional Gut Clinic to provide Hydrogen and Methane Breath Tests for detection of SIBO and carbohydrate malabsorption. This partnership is involved in studies related to early detection and precision medicine of gastrointestinal disease, as well as discovery of novel biomarkers. The Functional Gut Clinic operates three static clinics in London, Cambridge, and Manchester, plus mobile physiology services supporting over 20 NHS hospitals.
- Owlstone MedicalcoreOMED Health is a division of Owlstone Medical, the world leader in breath analysis. Owlstone Medical's mission is to save 100,000 lives and $1.5B in healthcare costs through early detection and precision medicine via Breath Biopsy technology. OMED Health benefits from Owlstone's world-class engineering and scientific expertise developed for the NHS and leading pharmaceutical partners.
- UK-Registered Partner PharmacycoreTrusted UK-registered pharmacy partner that processes prescriptions and dispenses medications prescribed by OMED Health doctors. Provides secure, confidential tracked delivery of prescriptions directly to patients' doors, with same-day or next-day delivery options.
- IBS ClinicsmajorIBS Clinics, specialists in IBS care, offers OMED Health SIBO testing to patients nationwide through the practitioner network.
- Practitioner Affiliates (Various)majorNetwork of independent practitioners including Mosaic Medical (Isobel Wilson - Functional Medicine), Total Gut Health (Violet Tomlinson - Colonic hydrotherapy), The Digital Dietitian (Aleks Jagiello - HCPC Registered Dietitian), Dr Asante's Gastroenterology Practice (Maxwell Asante - Consultant Gastroenterologist), Anna Pinnock Nutrition (Registered Nutritional Therapy Practitioner), Revolution Nutrition (Kirsty Groves - Registered Nutritionist/Nutritional Therapist), Katie Sanders Dietitian (Specialist Digestive Health Dietitian), and Tania Galvani Naturopath (Registered Naturopath and Nutritional Therapist).
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
OMED Health competitors and assessment
Company assessmentOthers
- Wisenbarrer / Wisent (diagnostic substrate manufacturers): Cambridge Isotope Laboratories and similar specialty manufacturers supply 13C-labeled and other substrates used in clinical breath tests. They are upstream suppliers/adjacents in the breath-testing value chain rather than direct competitors.
- Owlstone Medical: Owlstone Medical is OMED Health's parent company and the developer of the underlying Breath Biopsy platform. While not a peer in the narrow consumer gut-health sense, it is the technology and capability parent whose NHS and pharma programmes seed OMED's roadmap.
Direct peers
- Gemelli Biotech: Gemelli Biotech's Trio-Smart is the leading at-home SIBO/IMO breath test in North America, measuring hydrogen, methane, and hydrogen sulfide. It is the most direct competitive offering to OMED's Breath Analyzer and is sold through a similar practitioner-channel model.
- Commonwealth Diagnostics International: CDI provides SIBO and SIFO breath testing services to clinicians, including substrate kits and lab analysis. It is a direct peer in the SIBO diagnostics space, operating through a healthcare professional channel similar to OMED's Practitioner Portal model.
- QuinTron Instrument Company: QuinTron is a long-established manufacturer of breath test instrumentation and collection devices used in clinical SIBO and lactose intolerance testing. It supplies substrate kits and analyzers to hospital and reference labs, making it a comparable breath-testing hardware and substrate vendor.
- Bedfont Scientific: Bedfont makes handheld and clinic-based breath analysis monitors (NO, CO, H2, methane) used in gastroenterology, smoking cessation, and heliobacter pylori testing. Comparable breath analysis hardware vendor with overlapping clinical breath-testing product lines.
Emerging players
- BioHIT Healthcare: BioHIT produces Gastro+ Gastrolyzer, a hydrogen breath monitor used in SIBO, lactose intolerance and H. pylori testing. Comparable as a portable handheld H2 breath testing device vendor competing in the same clinician workflow.
- Zora Biosciences: Zora Biosciences develops breath-based diagnostic platforms using VOC analysis for disease detection, comparable in underlying technology approach (breath VOC fingerprinting) to OMED's Inside Insights product line.
- Vivante Health: Vivante Health offers digital therapeutics and gut health programs for IBS and digestive conditions, addressing the same IBS/SIBO patient population through a software + care team model rather than diagnostics hardware.
Regional players
- Functional Gut Clinic: Functional Gut Clinic operates specialist UK clinics running hydrogen and methane breath tests and is also an OMED Health partner. Operates in the same SIBO diagnostic category with a clinic-delivery model rather than OMED's at-home model, making it both a partner and an adjacent service competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
OMED Health social profiles
Digital presenceOMED Health compliance and trust
Trust signalCompliance3 records
OMED Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
OMED Health leadership team
Management profileNumber of profiles
Profiles3 records
OMED Health funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
OMED Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about OMED Health
What does OMED Health do?
OMED Health develops and sells the Breath Analyzer, a portable Class I IVD medical device that uses metal oxide sensors to measure hydrogen and methane gas concentrations in breath for at-home diagnosis of SIBO and IMO, paired with a smartphone app for guided testing. It also offers SIBO/IMO testing services reviewed by OMED doctors, antimicrobial and gut support supplements, prescription consultations, the Gut Reset+ personalised health plan, and the OMED Inside Insights in-clinic breath test, all supported by a Practitioner Portal for healthcare professionals.
Is OMED Health a public or private company?
OMED Health is a private company. It is classified as corporate owned and is currently operating.
When was OMED Health founded?
OMED Health was founded in 2022. It employs 51 to 100 people.
Where is OMED Health based?
OMED Health is headquartered in Cambridge, United Kingdom, in the Europe region.
How does OMED Health make money?
Five revenue lines are on record. Breath Analyzer Device Sales are the primary driver. The others are SIBO/IMO Testing Kits and Substrates, prescription Consultations and Medications, gut Health Supplements and health Plans (Gut Reset+).
Who are OMED Health's main competitors?
Others on record are Wisenbarrer / Wisent (diagnostic substrate manufacturers) and Owlstone Medical. Direct peers are Gemelli Biotech, Commonwealth Diagnostics International, QuinTron Instrument Company and Bedfont Scientific. Emerging players are BioHIT Healthcare, Zora Biosciences and Vivante Health. Functional Gut Clinic is listed as a regional player.
Does OMED Health have an API?
No public API is recorded for OMED Health.
What industry is OMED Health in?
OMED Health's product category is Medical Diagnostics. Its primary akta.pro industry code is HLAHACAD, Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry), with a secondary code of HLAHAGAI, Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate). Its NAICS code is 334510 and its SIC code is 2835.